Health Affairs Publishing’s Jeff Byers welcomes Georgetown University’s Katie Keith and Deputy Editor Chris Fleming back to the podcast to unpack a new court case over mifepristone that could alter telehealth access to medication abortion and test the boundaries of FDA authority.Join us on June 23 for an exclusive Insider virtual event examining how antitrust policy in health care is evolving at both the federal and state levels, featuring insights from Katherine Gudiksen, Leemore Dafny, and Nathan Hostert.Related Links:Supreme Court Temporarily Blocks Ruling Barring Telehealth And Pharmacy Access To Mifepristone (Health Affairs Forefront)The US Food and Drug Administration’s Regulation of Mifepristone (JAMA)Sign up for Health Affairs' free newsletter to catch up on our new articles, podcasts, and events.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Health Affairs This Week
How the One Big Beautiful Bill Changes Medicaid for Older Adults and State Health Policy
When Screening Guidelines Shift: Impacts on Healthcare Access & Use
Healthcare Price Transparency 2.0: Proposed Federal Updates Explained
New Prior Authorization Proposals: Implications for Prescription Drug Access
Get summaries like this every morning.
Free AI-powered recaps of Health Affairs This Week and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.